Biotech Stocks: Teva Up On M&a Deal; Elan, Biogen Slide
Source: MarketWatch
Thursday 18th March, 2010
BOSTON (MarketWatch) -- Teva Pharmaceutical Industries was the lead advancer among the large-cap drug stocks early Thursday, gaining on news that it plans to buy German generic drug-maker Ratiopharm G... ...
Read the full story at
MarketWatch
Email this story to a friend
Have your say on this story